Cell and Gene Therapy Summit 2024

April 15th and 16th 2024,  Brussels

Cell and gene therapies will reshape healthcare, but when?

With advances in technology and many innovative treatments on the horizon, cell and gene therapies can reshape healthcare, giving hope to patients who previously had no therapeutic options. But when will their potential be fully realised? Under the stewardship of The Economist’s editorial team, this event will convene industry leaders and healthcare stakeholders to debate the challenges of introducing advanced therapies into the mainstream. It will discuss changes in regulatory landscapes, delivery models, structuring clinical trials, and gathering real-world evidence that can improve patient access while ensuring companies maintain a competitive edge.

Flora Peyvandi, EAHAD’s former president, and Wolfgang Miesbach, EAHAD’s treasurer, will be gracing the stage as speakers on April 15, at 4.55 CEST. Their session “Spotlight on Haemophilia” will explore the challenges of data collection in hemophilia gene therapy and the heterogeneity of outcomes in haemophilia gene therapy trials.